Survival and mortality in hemodialysis patients

Authors

  • О.N. Sharapov Tashkent Pediatric Medical Institute, Tashkent, Uzbekistan; Republican Specialized Scientific and Practical Medical Center for Nephrology and Kidney Transplantation, Tashkent, Uzbekistan https://orcid.org/0000-0003-2452-416X

DOI:

https://doi.org/10.22141/2307-1257.10.1.2021.227211

Keywords:

chronic kidney disease, end-stage renal failure, renal replacement therapy, hemodialysis, survival, mortality

Abstract

This article provides a review of the literature on the problem of cardiovascular mortality in patients with end-stage renal disease. The article, based on foreign literature, considers the survival and mortality of hemodialysis patients. There is a high percentage of deaths due to cardiovascular pathologies in patients with end-stage renal disease receiving renal replacement therapy. The influence of cardiovascular pathologies on survival rates is described in detail according to the data of national and international renal registries. The data are provided on the study of the structure of the causes of death in hemodialysis patients. The factors influencing the survival rate and mortality in hemodialysis patients, such as smoking, preservation of diuresis, obesity, cholesterol concentration, serum potassium level, etc, are presented in detail. The urgency and necessity of studying this problem is noted, which dictates the need for purposeful efforts to reduce mortality in dialysis patients.

References

Farrington K, Covic A, Aucella F, et al. Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR <45 mL/min/1.73 m2). Nephrol Dial Transplant. 2016 Nov;31(Suppl 2):ii1-ii66. doi:10.1093/ndt/gfw356.

Van der Veer SN, van Biesen W, Bernaert P, et al. Priority topics for European multidisciplinary guidelines on the management of chronic kidney disease in older adults. Int Urol Nephrol. 2016 Jun;48(6):859-869. doi:10.1007/s11255-016-1257-4.

Nagler EV, Webster AC, Bolignano D, et al. European Renal Best Practice (ERBP) Guideline development methodology: towards the best possible guidelines. Nephrol Dial Transplant. 2014 Apr;29(4):731-738. doi:10.1093/ndt/gft407.

Bibkov BT, Tomilina NA. Renal replacement therapy for ESRD patients in Russian Federation, 1998-2009. Nephrology and Dialysis. 2011;13(3):150-264. (in Russian).

Smirnov AV, Dobronravov VA, Kayukov IG, Essaian AM. Chronic kidney disease: futher development of the conception and classification. Nephrology (Saint-Petersburg). 2007;11(4):7-17. doi:10.24884/1561-6274-2007-11-4-7-17. (in Russian).

Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013 Jan;3(1):1-150. doi:10.1038/kisup.2012.73.

Poulikakos D, Banerjee D, Malik M. Risk of sudden cardiac death in chronic kidney disease. J Cardiovasc Electrophysiol. 2014 Feb;25(2):222-231. doi:10.1111/jce.12328.

Green D, Roberts PR, New DI, Kalra PA. Sudden cardiac death in hemodialysis patients: an in-depth review. Am J Kidney Dis. 2011 Jun;57(6):921-929. doi:10.1053/j.ajkd.2011.02.376.

Chandrashekar A, Ramakrishnan S, Rangarajan D. Survival analysis of patients on maintenance hemodialysis. Indian J Nephrol. 2014 Jul;24(4):206-213. doi:10.4103/0971-4065.132985.

United States Renal Data System (USRDS). USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD, United States: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; 2012.

Pippias M, Stel VS, Abad Diez JM, et al. Renal replacement therapy in Europe: a summary of the 2012 ERA-EDTA Registry Annual Report. Clin Kidney J. 2015 Jun;8(3):248-261. doi:10.1093/ckj/sfv014.

Collins AJ, Foley RN, Gilbertson DT, Chen SC. United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease. Kidney Int Suppl (2011). 2015 Jun;5(1):2-7. doi:10.1038/kisup.2015.2.

Chen HS, Cheng CT, Hou CC, Liou HH, Lim PS. Survival and other clinical outcomes of maintenance hemodialysis patients in Taiwan: a 5-year multicenter follow-up study. Hemodial Int. 2014 Oct;18(4):799-808. doi:10.1111/hdi.12165.

Yamagata K, Nakai S, Iseki K, Tsubakihara Y; Committee of Renal Data Registry of the Japanese Society for Dialysis Therapy. Late dialysis start did not affect long-term outcome in Japanese dialysis patients: long-term prognosis from Japanese Society for [corrected] Dialysis Therapy Registry. Ther Apher Dial. 2012 Apr;16(2):111-120. doi:10.1111/j.1744-9987.2011.01052.x.

Gaipov A, Issanov A, Kadyrzhanuly K, et al. Epidemiology of dialysis-treated end-stage renal disease patients in Kazakhstan: data from nationwide large-scale registry 2014-2018. BMC Nephrol. 2020 Sep 21;21(1):407. doi:10.1186/s12882-020-02047-6.

Abramova EE, Koroleva IE, Tov NL, Movchan EA, Naborshchikov DA. Risk factors on lethal outcomes at patients on hemodialysis. Journal of Siberian Medical Sciences. 2015;(6):15-26. (in Russian).

Obi Y, Rhee CM, Mathew AT, et al. Residual Kidney Function Decline and Mortality in Incident Hemodialysis Patients. J Am Soc Nephrol. 2016 Dec;27(12):3758-3768. doi:10.1681/ASN.2015101142.

Brener ZZ, Kotanko P, Thijssen S, Winchester JF, Bergman M. Clinical benefit of preserving residual renal function in dialysis patients: an update for clinicians. Am J Med Sci. 2010 May;339(5):453-456. doi:10.1097/MAJ.0b013e3181cf7d5b.

Vilar E, Farrington K. Emerging importance of residual renal function in end-stage renal failure. Semin Dial. 2011 Sep-Oct;24(5):487-494. doi:10.1111/j.1525-139X.2011.00968.x.

Shafi T, Jaar BG, Plantinga LC, et al. Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis. 2010 Aug;56(2):348-358. doi:10.1053/j.ajkd.2010.03.020.

Araujo S, Lemes HP, Cunha DA, Queiroz VS, Nascimento DD, Ferreira Filho SR. Cardiac morphology and function in patients with and without residual diuresis on hemodialysis. J Bras Nefrol. 2011 Mar;33(1):74-81.

Tang W, Li LX, Pei J, Wang T. Heart rate variability in peritoneal dialysis patients: what is the role of residual renal function? Blood Purif. 2012;34(1):58-66. doi:10.1159/000338184.

Chen Y, Liu H, Zou J, et al. 24-h residual urine volume at hemodialysis initiation: a possible predictor for acute ischemic stroke incurrence in hemodialysis patients. Clin Neurol Neurosurg. 2013 May;115(5):557-561. doi:10.1016/j.clineuro.2012.06.028.

Ma T, Ding G. Effects of residual renal function on left ventricle and analysis of related factors in patients with hemodialysis. Ren Fail. 2013;35(2):198-203. doi:10.3109/0886022X.2012.745153.

Perl J, Bargman JM. The importance of residual kidney function for patients on dialysis: a critical review. Am J Kidney Dis. 2009 Jun;53(6):1068-1081. doi:10.1053/j.ajkd.2009.02.012.

Amaral S, Hwang W, Fivush B, Neu A, Frankenfield D, Furth S. Serum albumin level and risk for mortality and hospitalization in adolescents on hemodialysis. Clin J Am Soc Nephrol. 2008 May;3(3):759-767. doi:10.2215/CJN.02720707.

Combe C, McCullough KP, Asano Y, Ginsberg N, Maroni BJ, Pifer TB. Kidney Disease Outcomes Quality Initiative (K/DOQI) and the Dialysis Outcomes and Practice Patterns Study (DOPPS): nutrition guidelines, indicators, and practices. Am J Kidney Dis. 2004 Nov;44(5 Suppl 2):39-46. doi:10.1053/j.ajkd.2004.08.010.

Cooper BA, Penne EL, Bartlett LH, Pollock CA. Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. Am J Kidney Dis. 2004 Jan;43(1):61-66. doi:10.1053/j.ajkd.2003.08.045.

Rauchhaus M, Coats AJ, Anker SD. The endotoxin-lipoprotein hypothesis. Lancet. 2000 Sep 9;356(9233):930-933. doi:10.1016/S0140-6736(00)02690-8.

Liebman SE, Lamontagne SP, Huang LS, Messing S, Bushinsky DA. Smoking in dialysis patients: a systematic review and meta-analysis of mortality and cardiovascular morbidity. Am J Kidney Dis. 2011 Aug;58(2):257-265. doi:10.1053/j.ajkd.2011.03.025.

Kessler M, Zannad F, Lehert P, et al. Predictors of cardiovascular events in patients with end-stage renal disease: an analysis from the Fosinopril in dialysis study. Nephrol Dial Transplant. 2007 Dec;22(12):3573-3579. doi:10.1093/ndt/gfm417.

Suvorov AV, Zubeeva GN, Suslova OA, et al. Heart rhythm disruption and cardiovascular risk in patients with terminal chronic kidney disease being on program hemodialysis. Practical medicine. 2013;(3):77-80. (in Russian).

Chung SH, Han DC, Noh H, et al. Risk factors for mortality in diabetic peritoneal dialysis patients. Nephrol Dial Transplant. 2010 Nov;25(11):3742-37428. doi:10.1093/ndt/gfq233.

Tong J, Liu M, Li H, et al. Mortality and associated risk factors in dialysis patients with cardiovascular disease. Kidney Blood Press Res. 2016;41(4):479-487. doi:10.1159/000443449.

Wang HH, Hung SY, Sung JM, Hung KY, Wang JD. Risk of stroke in long-term dialysis patients compared with the general population. Am J Kidney Dis. 2014 Apr;63(4):604-611. doi:10.1053/j.ajkd.2013.10.013.

Drew DA, Sarnak MJ. Ischemic and hemorrhagic stroke: high incidence in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis. 2014 Apr;63(4):547-548. doi:10.1053/j.ajkd.2014.01.009.

Wu CK, Yang YH, Juang JJ, et al. Effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in dialysis patients: a nationwide data survey and propensity analysis. Medicine (Baltimore). 2015 Jan;94(3):e424. doi:10.1097/MD.0000000000000424.

Tang Y, Brooks JM, Wetmore JB, Shireman TI. Association between higher rates of cardioprotective drug use and survival in patients on dialysis. Res Social Adm Pharm. 2015 Nov-Dec;11(6):824-843. doi:10.1016/j.sapharm.2014.12.007.

Mokoli VM, Sumaili EK, Lepira FB, et al. Impact of residual urine volume decline on the survival of chronic hemodialysis patients in Kinshasa. BMC Nephrol. 2016 Nov 21;17(1):182. doi:10.1186/s12882-016-0401-9.

Bilevich OA, Ovsyannikov NV. Survival assessment of hemodialysis patients depending on the functional state parameters of cardiovascular system. Modern problems of science and education. 2015;(6):151. (in Russian).

Dalrymple LS, Mohammed SM, Mu Y, et al. Risk of cardiovascular events after infection-related hospitalizations in older patients on dialysis. Clin J Am Soc Nephrol. 2011 Jul;6(7):1708-1713. doi:10.2215/CJN.10151110.

Jung MY, Hwang SY, Hong YA, et al. Optimal hemoglobin level for anemia treatment in a cohort of hemodialysis patients. Kidney Res Clin Pract. 2015 Mar;34(1):20-27. doi:10.1016/j.krcp.2014.11.003.

Bradbury BD, Fissell RB, Albert JM, et al. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol. 2007 Jan;2(1):89-99. doi:10.2215/CJN.01170905.

Plantinga LC, Fink NE, Levin NW, et al. Early, intermediate, and long-term risk factors for mortality in incident dialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. Am J Kidney Dis. 2007 Jun;49(6):831-840. doi:10.1053/j.ajkd.2007.03.017.

Postorino M, Marino C, Tripepi G, Zoccali C; Calabrian Registry of Dialysis and Transplantation. Prognostic value of the New York Heart Association classification in end-stage renal disease. Nephrol Dial Transplant. 2007 May;22(5):1377-1382. doi:10.1093/ndt/gfl813.

Wolf M, Shah A, Gutierrez O, et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 2007 Oct;72(8):1004-1013. doi:10.1038/sj.ki.5002451.

Published

2021-04-16

Issue

Section

Reviews